Steel Therapeutics, Inc., an early stage pharmaceutical company focused on increasing access to compounded drug therapies, announced today that it has closed on $1.5M...
Specialty pharmaceutical company KemPharm this week postponed a special meeting that would have allowed shareholders to vote on a proposal authorizing its board to...
By CBJ News Staff
[email protected]
KemPharm, Inc. announced today the U.S. Food and Drug Administration had accepted the New Drug Application for its investigational attention deficit...